Neuroinflammation is a process that has gained increased attention in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, and has also been described in hepatic encephalopathy [3]. According to the data published in this issue of the Journal of Hepatology, neuroinflammation may also participate in more subtle neurological manifestations of liver disease. The article by Nguyen et al. investigates the underlying mechanisms of sickness behaviour in a murine model of cholestasic liver injury (bile duct ligation, BDL). In agreement with other studies [4], sickness behaviour is related to an increase in serum interleukin-6 (IL-6). In the current model, the generation of IL-6 was clearly shown to originate in the cholestasic liver and induced IL-6 signalling in the brain via endothelial activation, as suggested by an increase in the expression of p-STAT3 in endothelial cells of the hippocampus. These observations support the notion that systemic symptoms such as fatigue, frequently present in chronic cholestasic diseases, may originate from the effects of liver-induced inflammation on the brain. This is an interesting concept that may initiate a new approach for treating the symptoms associated with chronic liver disorders